Wikiwand AI

2C-G-5

Pharmaceutical compound From Wikipedia, the free encyclopedia

2C-G-5, also known as 3,4-norbornyl-2,5-dimethoxyphenethylamine, is a psychedelic drug of the phenethylamine and 2C families.[3][1][4][5][6][2] It is one of several homologues of 2C-G (3,4-dimethyl-2,5-dimethoxyphenethylamine).[1][4][5][6] The drug is taken orally.[1][4][5] 2C-G-5 was encountered online as a novel designer drug in 2025.[2]

Other names3,4-Norbornyl-2,5-DMPEA; 3,4-Norbornyl-2,5-dimethoxyphenethylamine; 2,5-Dimethoxy-3,4-norbornylphenethylamine; 3,6-Dimethoxy-4-(2-aminoethyl)benzonorbornane
ATC code
  • None
Quick facts Clinical data, Other names ...
2C-G-5
Clinical data
Other names3,4-Norbornyl-2,5-DMPEA; 3,4-Norbornyl-2,5-dimethoxyphenethylamine; 2,5-Dimethoxy-3,4-norbornylphenethylamine; 3,6-Dimethoxy-4-(2-aminoethyl)benzonorbornane
Routes of
administration
Oral[1]
Drug classSerotonergic psychedelic; Hallucinogen
ATC code
  • None
Pharmacokinetic data
Onset of action1–2 hours[1][2]
Duration of action32–48 hours[1][2]
Identifiers
  • 2-(3,6-dimethoxy-4-tricyclo[6.2.1.02,7]undeca-2,4,6-trienyl)ethanamine
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC15H21NO2
Molar mass247.338 g·mol−1
3D model (JSmol)
  • COC1=C2C3CCC(C3)C2=C(C(=C1)CCN)OC
  • InChI=1S/C15H21NO2/c1-17-12-8-11(5-6-16)15(18-2)14-10-4-3-9(7-10)13(12)14/h8-10H,3-7,16H2,1-2H3
  • Key:ASPWVWSIJQTXDB-UHFFFAOYSA-N
Close

Use and effects

In his book PiHKAL (Phenethylamines I Have Known and Loved) and other publications, Alexander Shulgin lists 2C-G-5's dose as 10 to 16 mg orally and its duration as 32 to 48 hours.[3][1][4][5][2] The drug's onset is 1 to 2 hours and its time to peak is 2.5 to 3 hours.[1][2] 2C-G-5 is reported to produce psychedelic effects including visuals, clear and cosmic thinking, and 2C-B-like enhanced eroticism, among others.[1][2] It is among the most potent of the 2C psychedelics.[1][4][5] However, its duration is described as too long, interfering with sleep and resulting in subsequent-day consequences like tiredness and sleepiness.[1][2] 2C-G-5 was also the longest-lasting drug included in PiHKAL based on its specified duration.[3][1]

Interactions

Pharmacology

Data on the pharmacology and toxicology of 2C-G-5 are unavailable.[2]

Chemistry

Synthesis

The chemical synthesis of 2C-G-5 has been described.[1]

Analogues

Analogues of 2C-G-5 include other compounds of the 2C-G and Ganesha series, among others.[3][1][6] Examples include 2C-G (2C-G-0), 2C-G-3, 2C-G-4, 2C-G-N, and G-5.[3][1][6]

History

2C-G-5 was first described in the literature by Alexander Shulgin in his 1991 book PiHKAL (Phenethylamines I Have Known and Loved).[1][4][5][6][2] It was encountered online as a novel designer drug in 2025.[2]

Society and culture

Canada

2C-G-5 is a controlled substance in Canada under phenethylamine blanket-ban language.[7]

United States

2C-G-5 is not an explicitly controlled substance in the United States.[8] However, it could be considered a controlled substance under the Federal Analogue Act if intended for human consumption.

See also

References

Related Articles

Timelines

Top Qs

Fact Checks